Chinese Journal of Pharmacovigilance ›› 2017, Vol. 14 ›› Issue (1): 4-6.
• Orignal Article • Previous Articles Next Articles
LIU Zhao-hua1, YAO Jing-chun2, SUN Rong3, GUO Yan-ru1, ZENG Fan-guang1
Received:
2017-02-16
Revised:
2017-02-16
Online:
2017-01-20
Published:
2017-02-16
CLC Number:
LIU Zhao-hua, YAO Jing-chun, SUN Rong, GUO Yan-ru, ZENG Fan-guang. Assessment of Immunosensitizing Potential of Shuanghuanglian for Injection Using Reporter Antigen Popliteal Lymph Node Assay[J]. Chinese Journal of Pharmacovigilance, 2017, 14(1): 4-6.
Add to citation manager EndNote|Ris|BibTeX
[1] 张玉生. 双黄连注射剂药物不良反应的探讨和研究[D], 济南:山东大学,2009. [2] 顾媛媛, 李殿明, 石朗,等. 注射用双黄连安全性问题研究近况[J]. 中国药房, 2015, (15):2156-2157. [3] Simons F E R, Frew A J, Ansotegui I J, et al. Risk assessment in anaphylaxis: current and future approaches[J]. J Allergy Clin Immunol,2007, 120(1): S2-24. [4] FDA. Guidance for Industry Immunotoxicology Evaluation of Investigational New Drugs[EB/OL].(2002-10-01)[2016-11-17].http://www.fda.gov/RegulatoryInformation/Guidances/default.htm. [5] CFDA.中药、天然药物免疫毒性(过敏性、光变态反应)研究技术指导原则[EB/OL].( 2007-08-23) [2016-11-17]. http://www.cde.org.cn/zdyz.do?method=initValue&frameStr=0. [6] CFDA.化学药物刺激性、过敏性和溶血性研究技术指导原则[EB/OL]. ( 2007-08-23) [2016-11-17]. http://www.cde.org.cn/zdyz.do?method=initValue&frameStr=0. [7] Tuschl H, Landsteiner H T, Kovac R. Application of the popliteal lymph node assay in immunotoxicity testing: complementation of the direct popliteal lymph node assay with flow cytometric analyses[J]. Toxicology, 2002, 172(1):35-48. [8] 刘兆华, 程芳, 周庚寅,等. C57BL/6J小鼠腘窝淋巴结试验评价注射用双黄连的致敏性研究[J]. 中国中西医结合杂志,2010, 30(1):64-67. [9] Aida T, Kimura T, Ishikawa N, et al. Evaluation of allergenic potential of low-molecular compounds by mouse popliteal lymph node assay[J].J Toxicol Sci, 1998, 23(5):425-432. [10] Løvik M, Alberg T, Nygaard U C, et al. Popliteal lymph node (PLN) assay to study adjuvant effects on respiratory allergy[J]. Methods,2007, 41(1):72-79. [11] Ravel G, Descotes J. Popliteal lymph node assay: facts and perspectives[J]. J Appl Toxicol, 2005, 25(6):451-458. [12] Gutting B W, Schomaker S J, Kaplan A H, et al. A comparison of the direct and reporter antigen popliteal lymph node assay for the detection of immunomodulation by low molecular weight compounds[J].Toxicol Sci, 1999, 51(1): 71-79. [13] Shinkai K, Nakamura K, Tsutsui N, et al. Mouse popliteal lymph node assay for assessment of allergic and autoimmunity-inducing potentials of low-molecular-weight drugs[J]. J Toxicol Sci, 1999, 24(2):95-102. [14] Carey J B, Allshire A, van Pelt F N. Immune modulation by cadmium and lead in the acute reporter antigen-popliteal lymph node assay[J]. Toxicol Sci, 2006, 91(1): 113-122. [15] Nierkens S, Pieters R. The Reporter Antigen Popliteal Lymph Node Assay[S/OL]. (2006-09-01)[2016-11-17]. http://www.currentprotocols.com/WileyCDA/CPUnit/refId-tx1812.html [16] 郝园, 孔翔瑜, 吴泰相. 277 篇 1486 例清开灵注射液不良反应/不良事件系统评价[J]. 中国循证医学杂志, 2010, 10(2): 162-175. [17] 程芳. 注射用双黄连类过敏反应及其机制研究[D]. 济南:山东大学,2009. [18] Uetrecht J. Idiosyncratic drug reactions: past, present, and future[J].Chem Res Toxicol, 2008, 21(1): 84-92. [19] Pieters R, Albers R. Screening tests for autoimmune-related immunotoxicity[J]. Environ Health Perspect, 1999, 107( Suppl 5): 673-677. [20] Pieters R. Detection of autoimmunity by pharmaceuticals[J]. Methods,2007, 41(1): 112-117. [21] Gutting B W, Updyke L W, Amacher D E. Amacher, Investigating the TNP-OVA and direct popliteal lymph node assays for the detection of immunostimulation by drugs associated with anaphylaxis in humans[J]. J Appl Toxicol, 2002, 22(3): 177-183. [22] Gutting B W, Updyke L W, Amacher D E. Diclofenac activates T cells in the direct popliteal lymph node assay and selectively induces IgG(1) and IgE against co-injected TNP-OVA[J]. Toxicol Lett, 2002, 131(3): 167-180. [23] Albers R, Broeders A, Van d P A, et al. The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals[J]. Toxicol Appl Pharmacol, 1997, 143(1): 102-109. [24] 张晶, 周富荣. 中药注射剂质量标准及有关问题评述[J]. 中药新药与临床药理, 2001, 12(002): 67-73. [25] Han J, Yan Y, Li C, et al. Involvement of Histamine and RhoA/ROCK in Penicillin Immediate Hypersensitivity Reactions[J].Scientific Reports, 2016, 6:33192. [26] 仇士东, 刘兆华,刘兆平. 双黄连注射剂导致类过敏反应的特点[J]. 中国药理学与毒理学杂志, 2013, 27(5): 818-824. |
[1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
[2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
[3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
[4] | SHI Yanlei, ZHANG Bing, WANG Yu, XU Zhuoxin, TIAN Min, MENG Min, SA Rina. Doxorubicin-Induced Cardiotoxicity Related to Regulation of Mitochondrial-Associated Membranes by PDK4 [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 863-868. |
[5] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
[6] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
[7] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
[8] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
[9] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
[10] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
[11] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
[12] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
[13] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
[14] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
[15] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||